Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renaud A Du Pasquier

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2019
Pembrolizumab as a treatment for PML? Waiting for GodotRenaud A Du Pasquier
Current Opinion in Neurology|May 6, 2010
A promenade along the stream of demyelinationRenaud A Du Pasquier
Antiviral Therapy|March 15, 2013
A light in the cognitive fog?Matthias Cavassini, Renaud A Du Pasquier
Current Opinion in Neurology|May 6, 2010
Demyelination as a complication of new immunomodulatory treatmentsAndreas P Lysandropoulos, Renaud A Du Pasquier
Journal of Neurovirology|April 24, 2003
Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?Renaud A Du Pasquier, Igor J Koralnik
Neurology. Clinical Practice|February 15, 2018
Posterior spinal cord infarctions due to neurosyphilisOlivier Bill, Renaud A Du Pasquier, Patrik Michel
Neurology|August 28, 2013
Author ResponseRenaud A Du Pasquier, Mathieu Canales, Myriam Schluep
CNS Drugs|April 12, 2014
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosisRenaud A Du Pasquier, Daniel D Pinschewer, Doron Merkler
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2012
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjectsSamantha Jilek, Myriam Schluep, Giuseppe Pantaleo, et al.
Cellular and Molecular Life Sciences : CMLS|April 25, 2012
Type I IFN-mediated regulation of IL-1 production in inflammatory disordersKristina Ludigs, Valeriy Parfenov, Renaud A Du Pasquier, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2019
Pembrolizumab as a treatment for PML? Waiting for GodotRenaud A Du Pasquier
Current Opinion in Neurology|May 6, 2010
A promenade along the stream of demyelinationRenaud A Du Pasquier
Antiviral Therapy|March 15, 2013
A light in the cognitive fog?Matthias Cavassini, Renaud A Du Pasquier
Current Opinion in Neurology|May 6, 2010
Demyelination as a complication of new immunomodulatory treatmentsAndreas P Lysandropoulos, Renaud A Du Pasquier
Journal of Neurovirology|April 24, 2003
Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?Renaud A Du Pasquier, Igor J Koralnik
Neurology. Clinical Practice|February 15, 2018
Posterior spinal cord infarctions due to neurosyphilisOlivier Bill, Renaud A Du Pasquier, Patrik Michel
Neurology|August 28, 2013
Author ResponseRenaud A Du Pasquier, Mathieu Canales, Myriam Schluep
CNS Drugs|April 12, 2014
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosisRenaud A Du Pasquier, Daniel D Pinschewer, Doron Merkler
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 4, 2012
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjectsSamantha Jilek, Myriam Schluep, Giuseppe Pantaleo, et al.
Cellular and Molecular Life Sciences : CMLS|April 25, 2012
Type I IFN-mediated regulation of IL-1 production in inflammatory disordersKristina Ludigs, Valeriy Parfenov, Renaud A Du Pasquier, et al.
Pageof 7